tranexamic acid has been researched along with Granulomatosis with Polyangiitis in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Granulomatosis with Polyangiitis: A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lundin, MS | 1 |
| Kaw, B | 1 |
| Pahwa, R | 1 |
1 other study available for tranexamic acid and Granulomatosis with Polyangiitis
| Article | Year |
|---|---|
Syndrome of inappropriate antidiuretic hormone associated with eosinophilic granulomatosis and polyangiitis.
Topics: Antifibrinolytic Agents; Churg-Strauss Syndrome; Granulomatosis with Polyangiitis; Humans; Inappropr | 2020 |